TABITHA SMITH: Open Payments
NPI 1003112277 · WOODBURY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,846 in 126 payments from 27 companies in 2025. Trend: 2023 $1,515 · 2024 $1,647 · 2025 $2,846
Food & beverage: $2,846
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $662 |
| Otsuka America Pharmaceutical, Inc. | 17 | $356 |
| Axsome Therapeutics, Inc. | 12 | $309 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $225 |
| Novo Nordisk Inc | 10 | $158 |
| Vanda Pharmaceuticals Inc. | 9 | $157 |
| Mannkind Corporation | 5 | $154 |
| Amgen Inc. | 12 | $148 |
| Alkermes, Inc. | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
Products named: REXULTI, Auvelity, VRAYLAR, BOTOX, CAPLYTA, FANAPT, AFREZZA, OTEZLA.
Industry payments across TN — which companies pay providers there.
